Dr. Amy Kao of the Allegheny-Singer Research Institute in Pittsburgh, discusses her research to evaluate the use of CD4 molecules on T-cells as a possible marker for diagnosing lupus nephritis and the potential benefits of a marker for this serious complication of lupus.
Dr. Jill Buyon of the New York University School of Medicine, a leading authority on congenital heart block in neonatal lupus, discusses this rare complication and the next steps in the study of neonatal lupus.
Dr. Kathleen O'Neil discusses a multi-center longitudinal observational study of girls with prepubertal onset lupus as they approach and pass through puberty, measuring hormone levels, autoantibodies and markers of lupus activity.
Dr. David Pisetsky of the Duke University Medical Center, discusses where lupus research may be headed in the coming years.
Dr. Gregg Silverman of the University of California, San Diego, discusses how the field of lupus genetics has evolved and where the field is headed in the next several years.
Dr. Gregg Silverman discusses B-cells and how they contribute to the development of lupus and offers insight on the future direction of lupus research.
Dr. David Pisetsky of Duke University Medical Center discusses the role of apoptosis (programmed cell death) and microparticles in triggering lupus.
Dr. David Pisetsky of Duke University Medical Center discusses immune response to DNA and its role in stimulating lupus.